Construction of a single-cycle replication recombinant infectious laryngotracheitis virus lacking the glycoprotein H gene and evaluation of its role in viral entry and infectivity
Parisa Jamour, Abbas Jamali, Arash Ghalyanchi Langeroudi, Sara Yahyaie, Setare Adibzadeh, Behrouz Ebadi sharafabad, Asghar Abdoli
{"title":"Construction of a single-cycle replication recombinant infectious laryngotracheitis virus lacking the glycoprotein H gene and evaluation of its role in viral entry and infectivity","authors":"Parisa Jamour, Abbas Jamali, Arash Ghalyanchi Langeroudi, Sara Yahyaie, Setare Adibzadeh, Behrouz Ebadi sharafabad, Asghar Abdoli","doi":"10.1007/s00705-025-06302-9","DOIUrl":null,"url":null,"abstract":"<div><p>Infectious laryngotracheitis virus (ILTV), a significant avian pathogen belonging to the subfamily <i>Alphaherpesvirinae</i>, causes severe respiratory disease, particularly in unvaccinated flocks. In this study, we produced a recombinant ILTV lacking the essential envelope glycoprotein H (gH), a key determinant of viral entry and propagation. To achieve this, we engineered an ILTV mutant with the gH gene replaced by a BleCherry fluorescent reporter cassette. This modification enabled the identification and isolation of recombinant viruses through red fluorescence. To facilitate the replication of this gH-deficient mutant, we generated a stable Vero cell line expressing gH and a green fluorescent protein (GFP) reporter. This engineered cell line proved crucial for generating the recombinant ILTV and allowing controlled single-cycle replication. The recombinant ILTV exhibited enhanced viability across a range of multiplicities of infection (MOIs), although with a significant reduction in overall viral replication. Importantly, the modified virus is unable to replicate in the absence of exogenous gH, minimizing the risks associated with viral spread and unintended infections. This novel single-cycle recombinant ILTV platform holds significant promise for various applications, including safe gene delivery and the development of improved vaccine strategies for enhanced avian health management and disease control.</p></div>","PeriodicalId":8359,"journal":{"name":"Archives of Virology","volume":"170 6","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Virology","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s00705-025-06302-9","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"VIROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Infectious laryngotracheitis virus (ILTV), a significant avian pathogen belonging to the subfamily Alphaherpesvirinae, causes severe respiratory disease, particularly in unvaccinated flocks. In this study, we produced a recombinant ILTV lacking the essential envelope glycoprotein H (gH), a key determinant of viral entry and propagation. To achieve this, we engineered an ILTV mutant with the gH gene replaced by a BleCherry fluorescent reporter cassette. This modification enabled the identification and isolation of recombinant viruses through red fluorescence. To facilitate the replication of this gH-deficient mutant, we generated a stable Vero cell line expressing gH and a green fluorescent protein (GFP) reporter. This engineered cell line proved crucial for generating the recombinant ILTV and allowing controlled single-cycle replication. The recombinant ILTV exhibited enhanced viability across a range of multiplicities of infection (MOIs), although with a significant reduction in overall viral replication. Importantly, the modified virus is unable to replicate in the absence of exogenous gH, minimizing the risks associated with viral spread and unintended infections. This novel single-cycle recombinant ILTV platform holds significant promise for various applications, including safe gene delivery and the development of improved vaccine strategies for enhanced avian health management and disease control.
期刊介绍:
Archives of Virology publishes original contributions from all branches of research on viruses, virus-like agents, and virus infections of humans, animals, plants, insects, and bacteria. Coverage spans a broad spectrum of topics, from descriptions of newly discovered viruses, to studies of virus structure, composition, and genetics, to studies of virus interactions with host cells, organisms and populations. Studies employ molecular biologic, molecular genetics, and current immunologic and epidemiologic approaches. Contents include studies on the molecular pathogenesis, pathophysiology, and genetics of virus infections in individual hosts, and studies on the molecular epidemiology of virus infections in populations. Also included are studies involving applied research such as diagnostic technology development, monoclonal antibody panel development, vaccine development, and antiviral drug development.Archives of Virology wishes to publish obituaries of recently deceased well-known virologists and leading figures in virology.